1. Home
  2. CDTX vs LGI Comparison

CDTX vs LGI Comparison

Compare CDTX & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • LGI
  • Stock Information
  • Founded
  • CDTX 2012
  • LGI 2004
  • Country
  • CDTX United States
  • LGI United States
  • Employees
  • CDTX N/A
  • LGI N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • LGI
  • Sector
  • CDTX Health Care
  • LGI
  • Exchange
  • CDTX Nasdaq
  • LGI Nasdaq
  • Market Cap
  • CDTX 242.5M
  • LGI 219.9M
  • IPO Year
  • CDTX 2015
  • LGI N/A
  • Fundamental
  • Price
  • CDTX $20.53
  • LGI $15.90
  • Analyst Decision
  • CDTX Strong Buy
  • LGI
  • Analyst Count
  • CDTX 6
  • LGI 0
  • Target Price
  • CDTX $32.20
  • LGI N/A
  • AVG Volume (30 Days)
  • CDTX 86.5K
  • LGI 41.1K
  • Earning Date
  • CDTX 11-07-2024
  • LGI 01-01-0001
  • Dividend Yield
  • CDTX N/A
  • LGI 7.10%
  • EPS Growth
  • CDTX N/A
  • LGI N/A
  • EPS
  • CDTX N/A
  • LGI N/A
  • Revenue
  • CDTX $44,653,000.00
  • LGI N/A
  • Revenue This Year
  • CDTX N/A
  • LGI N/A
  • Revenue Next Year
  • CDTX N/A
  • LGI N/A
  • P/E Ratio
  • CDTX N/A
  • LGI N/A
  • Revenue Growth
  • CDTX 44.48
  • LGI N/A
  • 52 Week Low
  • CDTX $10.00
  • LGI $12.66
  • 52 Week High
  • CDTX $24.99
  • LGI $16.68
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 55.06
  • LGI 27.40
  • Support Level
  • CDTX $21.15
  • LGI $16.47
  • Resistance Level
  • CDTX $24.99
  • LGI $16.74
  • Average True Range (ATR)
  • CDTX 2.10
  • LGI 0.21
  • MACD
  • CDTX -0.15
  • LGI -0.07
  • Stochastic Oscillator
  • CDTX 41.16
  • LGI 5.26

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About LGI Lazard Global Total Return and Income Fund

Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt, and others.

Share on Social Networks: